Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Mitochondrial and cellular proteins refers to the vast and diverse collection of proteins residing within the mitochondria and the broader cellular environment, rather than a single, specific therapeutic target. Mitochondria alone contain approximately 1,100 to 1,500 distinct proteins that are essential for ATP production via oxidative phosphorylation, the regulation of apoptosis, and various metabolic pathways such as the citric acid cycle (Rath et al., 2021, Nucleic Acids Res). Cellular proteins encompass the entire proteome, including enzymes, receptors, and structural proteins that maintain cell integrity and function. Because this term aggregates thousands of different molecules with widely varying functions, it does not meet the criteria for a specific drug target in modern pharmacology. Drug development typically focuses on individual proteins or specific complexes to achieve selectivity and minimize off-target effects (Santos et al., 2017, Nat Rev Drug Discov).
Not applicable as this is a collective term for thousands of distinct functional entities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial and cellular proteins.